Cargando…

Classification of diabetic retinopathy: Past, present and future

Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhengwei, Tan, Tien-En, Shao, Yan, Wong, Tien Yin, Li, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800497/
https://www.ncbi.nlm.nih.gov/pubmed/36589807
http://dx.doi.org/10.3389/fendo.2022.1079217
_version_ 1784861301889040384
author Yang, Zhengwei
Tan, Tien-En
Shao, Yan
Wong, Tien Yin
Li, Xiaorong
author_facet Yang, Zhengwei
Tan, Tien-En
Shao, Yan
Wong, Tien Yin
Li, Xiaorong
author_sort Yang, Zhengwei
collection PubMed
description Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved as understanding of disease pathophysiology improved, methods of imaging and assessing DR changed, and effective treatments were developed. Current DR classification systems are effective, and have been the basis of major research trials and clinical management guidelines for decades. However, with further new developments such as recognition of diabetic retinal neurodegeneration, new imaging platforms such as optical coherence tomography and ultra wide-field retinal imaging, artificial intelligence and new treatments, our current classification systems have significant limitations that need to be addressed. In this paper, we provide a historical review of different classification systems for DR, and discuss the limitations of our current classification systems in the context of new developments. We also review the implications of new developments in the field, to see how they might feature in a future, updated classification.
format Online
Article
Text
id pubmed-9800497
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98004972022-12-31 Classification of diabetic retinopathy: Past, present and future Yang, Zhengwei Tan, Tien-En Shao, Yan Wong, Tien Yin Li, Xiaorong Front Endocrinol (Lausanne) Endocrinology Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved as understanding of disease pathophysiology improved, methods of imaging and assessing DR changed, and effective treatments were developed. Current DR classification systems are effective, and have been the basis of major research trials and clinical management guidelines for decades. However, with further new developments such as recognition of diabetic retinal neurodegeneration, new imaging platforms such as optical coherence tomography and ultra wide-field retinal imaging, artificial intelligence and new treatments, our current classification systems have significant limitations that need to be addressed. In this paper, we provide a historical review of different classification systems for DR, and discuss the limitations of our current classification systems in the context of new developments. We also review the implications of new developments in the field, to see how they might feature in a future, updated classification. Frontiers Media S.A. 2022-12-16 /pmc/articles/PMC9800497/ /pubmed/36589807 http://dx.doi.org/10.3389/fendo.2022.1079217 Text en Copyright © 2022 Yang, Tan, Shao, Wong and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yang, Zhengwei
Tan, Tien-En
Shao, Yan
Wong, Tien Yin
Li, Xiaorong
Classification of diabetic retinopathy: Past, present and future
title Classification of diabetic retinopathy: Past, present and future
title_full Classification of diabetic retinopathy: Past, present and future
title_fullStr Classification of diabetic retinopathy: Past, present and future
title_full_unstemmed Classification of diabetic retinopathy: Past, present and future
title_short Classification of diabetic retinopathy: Past, present and future
title_sort classification of diabetic retinopathy: past, present and future
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800497/
https://www.ncbi.nlm.nih.gov/pubmed/36589807
http://dx.doi.org/10.3389/fendo.2022.1079217
work_keys_str_mv AT yangzhengwei classificationofdiabeticretinopathypastpresentandfuture
AT tantienen classificationofdiabeticretinopathypastpresentandfuture
AT shaoyan classificationofdiabeticretinopathypastpresentandfuture
AT wongtienyin classificationofdiabeticretinopathypastpresentandfuture
AT lixiaorong classificationofdiabeticretinopathypastpresentandfuture